HomeCompareGMTX vs RYLD

GMTX vs RYLD: Dividend Comparison 2026

GMTX yields 148.15% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GMTX wins by $23.41M in total portfolio value
10 years
GMTX
GMTX
● Live price
148.15%
Share price
$1.35
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.46M
Annual income
$10,076,148.54
Full GMTX calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — GMTX vs RYLD

📍 GMTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGMTXRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GMTX + RYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GMTX pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GMTX
Annual income on $10K today (after 15% tax)
$12,592.59/yr
After 10yr DRIP, annual income (after tax)
$8,564,726.26/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, GMTX beats the other by $8,562,527.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GMTX + RYLD for your $10,000?

GMTX: 50%RYLD: 50%
100% RYLD50/50100% GMTX
Portfolio after 10yr
$11.75M
Annual income
$5,039,367.94/yr
Blended yield
42.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GMTX right now

GMTX
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.6
Piotroski
1/9
RYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GMTX buys
0
RYLD buys
0
No recent congressional trades found for GMTX or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGMTXRYLD
Forward yield148.15%12.14%
Annual dividend / share$2.00$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$23.46M$44.5K
Annual income after 10y$10,076,148.54$2,587.35
Total dividends collected$21.69M$18.8K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: GMTX vs RYLD ($10,000, DRIP)

YearGMTX PortfolioGMTX Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$25,515$14,814.81$11,914$1,213.65+$13.6KGMTX
2$62,628$35,326.85$14,099$1,351.30+$48.5KGMTX
3$148,051$81,039.20$16,580$1,494.55+$131.5KGMTX
4$337,457$179,042.34$19,384$1,642.61+$318.1KGMTX
5$742,477$381,398.70$22,535$1,794.70+$719.9KGMTX
6$1,578,712$784,260.93$26,063$1,950.00+$1.55MGMTX
7$3,247,684$1,558,462.68$29,995$2,107.69+$3.22MGMTX
8$6,471,310$2,996,288.20$34,361$2,266.99+$6.44MGMTX
9$12,504,097$5,579,794.89$39,194$2,427.12+$12.46MGMTX
10$23,455,532$10,076,148.54$44,525$2,587.35+$23.41MGMTX

GMTX vs RYLD: Complete Analysis 2026

GMTXStock

Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 for treatment of systemic diseases. Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.

Full GMTX Calculator →

RYLDETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this GMTX vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GMTX vs SCHDGMTX vs JEPIGMTX vs OGMTX vs KOGMTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.